Evidence map›Paper›PMID 41681887›Full record

ArticleCancers2026

High-Dose Intravenous Ferric Carboxymaltose/Derisomaltose Without ESAs for Cancer-Related Anemia in Japan: A Retrospective Single-Center Cohort Study.

Shinya Kajiura, Yudai Ishikawa, Yoko Mizuno, Akihiro Yoshida, Ryutatsu Yuki, Toshihito Horikawa, Mutsuki Furukawa, Kohei Nagata, Iori Motoo, Takayuki Ando and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shinya KajiuraDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.ORCID 0000-0003-4920-5130
Yudai IshikawaDepartment of Hospital Pharmacy, Toyama University Hospital, Toyama 930-0194, Japan.
Yoko MizunoDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
Akihiro YoshidaDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
Ryutatsu YukiPalliative Care Team, Toyama University Hospital, Toyama 930-0194, Japan.
Toshihito HorikawaDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
Mutsuki FurukawaDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
Kohei NagataThird Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Iori MotooThird Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Takayuki AndoThird Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Ichiro YasudaThird Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0002-6888-0310
Atsushi KatoThird Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0001-8022-196X
Ryuji HayashiDepartment of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama 930-0194, Japan.ORCID 0000-0002-4205-9540

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer-related anemiaferric carboxymaltoseferric derisomaltosefunctional iron deficiencyhypophosphatemiaintravenous irononcologyreal-world evidencesupportive caretransfusion avoidance

Identifiers

PMID41681887
PMCPMC12896494

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.